RAPPORT THERAPEUTICS INC.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About RAPP
Rapport Therapeutics, Inc. is a clinical-stage biotechnology company engaged in discovering and developing small-molecule precision medicines for patients with neurological or psychiatric disorders. It has made discoveries related to the function of receptor-associated proteins (RAPs) in the brain. Its RAP technology platform enables a differentiated approach to generate precision small molecule product candidates with the potential to overcome many limitations of conventional neurology drug discovery. Its precision neuroscience pipeline includes its lead investigational drug, RAP-219, designed to achieve neuroanatomical specificity through its selective targeting of a RAP expressed in only discrete regions of the brain. It is pursuing RAP-219 as a treatment for refractory focal epilepsy, bipolar mania and diabetic peripheral neuropathic pain. Additional preclinical and late-stage discovery stage programs are also underway, including targeting chronic pain and hearing disorders.
Find out what a historical investment in RAPPORT THERAPEUTICS INC. would be worth today using our RAPP stock calculator.
$1.44B
-
0.00%
312.89K
$30.50
$28.03
$28.82
$42.27
$6.43
Ready to start your investing journey with Stake?
Open an accountRAPP FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in RAPP
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RAPP
on Stake
Buy RAPP from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of RAPP from only US$10 with fractional shares
